Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.81
+0.75 (5.74%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $203.36 million as of September 11, 2026. Its market cap has decreased by -39.02% in one year.
Market Cap
203.36M
Enterprise Value
107.65M
1-Year Change
-39.02%
Ranking
Category
Stock Price
$13.81
ChartMarket Cap Chart
Since November 6, 2023, Korro Bio's market cap has increased from $123.80M to $203.36M, an increase of 64.27%. That is a compound annual growth rate of 19.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 203.36M | 169.59% |
| Dec 31, 2025 | 75.43M | -78.85% |
| Dec 31, 2024 | 356.65M | -6.96% |
| Dec 29, 2023 | 383.31M | 209.63% |
| Nov 6, 2023 | 123.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 208.78M |
| Nkarta | 208.43M |
| PepGen | 206.39M |
| Coherus Oncology | 205.49M |
| AN2 Therapeutics | 204.15M |
| Tonix Pharmaceuticals Holding | 203.58M |
| Satellos Bioscience | 201.88M |
| Armata Pharmaceuticals | 200.04M |